U.S. Post-Approval Study Results Presented at Heart Failure Society of America Annual MeetingMARLTON, N.J., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful ...

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. The first ...

Researchers at Google have spent years developing the company’s specialized medical chatbot, called AMIE, short for ...

General-purpose AI can identify broad patterns, but clinical development demands models that understand the complex relationships within life sciences data. In this sponsored episode of The Top Line, ...

Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...

Connecting people with clinical trials is complicated – even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and ...

SHELTON, CT / ACCESS Newswire / October 5, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said ...

The ACT EU pilot scheme was introduced in 2024 and will now become a permanent feature for EU trials.